Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Dec 27, 2023; 15(12): 2855-2865
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2855
Published online Dec 27, 2023. doi: 10.4240/wjgs.v15.i12.2855
Figure 4 The co-occurrence and exclusion mutation relationships from the top 15 mutated genes in the samples.
TP53 and CDH1 were exclusively mutated with P < 0.1, suggesting two different patterns in the pathogenesis of gastric adenocarcinoma. aP 0.05; bP 0.1.
- Citation: Liu HL, Peng H, Huang CH, Zhou HY, Ge J. Mutational separation and clinical outcomes of TP53 and CDH1 in gastric cancer. World J Gastrointest Surg 2023; 15(12): 2855-2865
- URL: https://www.wjgnet.com/1948-9366/full/v15/i12/2855.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i12.2855